What happens when you take smoking with insulin?
Smoking and insulin pull glucose control in opposite directions through several mechanisms that all blunt how well insulin works. Each one adds up, so the combination matters more than any single effect.
- Acute insulin resistance. Nicotine triggers a release of catecholamines (epinephrine and norepinephrine) and cortisol, which raise the liver's glucose output and reduce how much glucose your muscles take up. Measurable signs of insulin resistance in skeletal muscle can appear within about an hour of smoking.
- Chronic metabolic damage. Long-term smoking causes systemic oxidative stress, low-grade inflammation, endothelial dysfunction, and accumulation of visceral fat. Each of these independently worsens insulin sensitivity over months and years. Registry data, including the Fukuoka Diabetes Registry, show a dose-dependent rise in HbA1c and insulin resistance with heavier and longer smoking.
- Slowed insulin absorption. Smoking causes peripheral vasoconstriction, which narrows the small blood vessels feeding subcutaneous tissue. That slows how quickly injected insulin is absorbed, so the same dose produces a flatter, more delayed effect in a smoker, contributing to higher post-meal glucose and weaker overnight control.
The combined result is that people with diabetes who smoke generally need more total daily insulin than otherwise comparable non-smokers to reach the same HbA1c. The exact amount varies with how much someone smokes, the type of diabetes, baseline insulin sensitivity, and body weight, so there is no single number that fits everyone.
Why is this important?
Insulin dosing is one of the most consequential decisions in diabetes care. Too little insulin causes high glucose, with its long-term complications: damage to the eyes, kidneys, nerves, and heart and blood vessels. Too much insulin causes low glucose, which is acutely dangerous and can be life-threatening. Because smoking changes the dose needed, any change in smoking habit can tip the balance toward either problem.
The riskier moment is usually the quit attempt itself, not the long term. When a person with diabetes stops smoking, insulin sensitivity improves over days to weeks. If the insulin dose is not lowered to match, units that used to be appropriate may now drive glucose dangerously low, especially overnight. Clinical reports describe nocturnal lows and more frequent hypoglycemia in the first weeks after quitting.
It can also be confusing that several large studies show a modest, temporary rise in new diabetes diagnoses in the first few years after quitting, driven mostly by post-cessation weight gain and closer medical follow-up. This does not mean quitting is bad for diabetes. Long-term heart, blood-vessel, and microvascular outcomes are clearly better in people who quit. It simply means the quit attempt deserves attentive diabetes management.
What should you do?
Before any change: Tell your diabetes team if you smoke, vape, or use other nicotine products, and let them know before you start a quit attempt. Ask in advance what insulin reduction they would want you to make if your glucose readings start drifting downward, so you have a plan rather than guessing in the moment. Agree on how often to check glucose during the transition.
Every day during the transition: Check your blood glucose more often during the first few weeks of stopping. Continuous glucose monitoring is especially helpful here because it captures overnight lows and downward trends that finger-stick checks can miss. Set low-glucose alarms if your monitor supports them, keep fast-acting glucose nearby, and be more cautious with exercise in the early weeks.
After things settle: Watch for weight gain, which is common after quitting and can partly offset the improvement in insulin sensitivity. The net effect of quitting is still strongly positive. Keep adjusting diet, activity, and insulin doses with your team as your insulin sensitivity stabilizes. Nicotine replacement therapy, varenicline, and bupropion are all compatible with insulin and improve the odds of quitting successfully.
Which specific products are affected?
This interaction applies to all insulin preparations: rapid-acting analogs (lispro, aspart, glulisine, and ultra-rapid versions), short-acting human insulin (Regular), intermediate-acting (NPH), long-acting analogs (glargine, detemir, degludec), pre-mixed combinations, and inhaled insulin (Afrezza). The absorption-slowing effect from vasoconstriction is most relevant for insulin injected under the skin.
On the smoking side, the effect comes from cigarettes, cigars, pipes, hookah, and cannabis combustion products. Nicotine pouches, vapes, smokeless tobacco, and nicotine replacement therapy still deliver nicotine, so they still act on catecholamines, glucose output, and insulin sensitivity, though typically less than active smoking and without the extra combustion-related oxidative stress.
People with type 2 diabetes on non-insulin medicines (metformin, GLP-1 agonists, SGLT2 inhibitors, sulfonylureas) face the same smoking-related insulin resistance, even though the dose-adjustment logic differs.
The science behind it
The clearest evidence comes from the Fukuoka Diabetes Registry (Ohkuma T et al., PLoS One 2015), a registry cohort of roughly 2,490 men with type 2 diabetes. It found a dose- and time-dependent association between smoking and worse glycemic control and insulin resistance, and a roughly linear improvement after cessation, supporting both the direction and the mechanism described above.
A clinical review of tobacco and diabetes (Endocrinologia, Diabetes y Nutricion) summarizes how cigarette smoking promotes insulin resistance and how smoking-related vasoconstriction slows subcutaneous insulin absorption, raising insulin requirements. Together these sources support the direction of the interaction; precise per-person dose changes are individual and not something to estimate from population averages.
Frequently Asked Questions
Does smoking make my insulin work less well?
Yes. Smoking both worsens insulin resistance and slows how quickly injected insulin is absorbed, so the same dose tends to do less for a smoker than for a non-smoker.
Will I need to change my insulin when I quit?
Often, yes. Insulin sensitivity improves within days to weeks of stopping, so many people need less insulin to avoid lows. Plan this with your diabetes team rather than adjusting on your own.
Why might my glucose go low after I quit smoking?
As insulin starts working more effectively again, your previous dose can become too strong, especially overnight. That is why closer monitoring and a pre-agreed reduction plan matter in the first weeks.
Do vaping and nicotine pouches count?
They still deliver nicotine, so they still affect catecholamines and insulin sensitivity, generally less than active smoking. Nicotine replacement therapy used to help you quit is compatible with insulin.
I heard quitting can cause diabetes - should I keep smoking?
No. The temporary rise in diabetes diagnoses after quitting reflects weight gain and closer follow-up, not harm from quitting. Long-term heart and blood-vessel outcomes are clearly better after quitting.
What should I keep on hand during a quit attempt?
Keep fast-acting glucose nearby, monitor glucose more frequently (ideally with continuous glucose monitoring), and be a bit more cautious with exercise in the early weeks.
Key takeaways
- Smoking worsens insulin resistance and slows insulin absorption, so people with diabetes who smoke usually need more insulin than non-smokers.
- Quitting improves insulin sensitivity within days to weeks, so insulin doses often need to come down to avoid lows.
- Plan quit attempts with your diabetes team and agree in advance on how much to reduce insulin if readings drift down.
- Monitor glucose closely for the first weeks of quitting, ideally with continuous glucose monitoring, and keep fast-acting glucose nearby.
- The long-term cardiovascular benefit of quitting far outweighs the short-term dose-adjustment work.